Europe — EMA

Palexia Retard (Tapentadol Hydrochloride)

Tapentadol Hydrochloride, the active ingredient in Palexia Retard, is an opioid analgesic presented as a unknown/unknown for oral use.

Tapentadol Hydrochloride

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

Pack/s

What is Tapentadol Hydrochloride?

Tapentadol Hydrochloride, the active ingredient in Palexia Retard, is an opioid analgesic presented as a unknown/unknown for oral use. It treats moderate to severe acute pain in adult patients when opioid treatment is needed.

GNH USA supplies Palexia Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tapentadol Hydrochloride used for?

Palexia Retard is a strong strong ... ... ... ... ... ... .... ... ... .... ... ... ... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →